Chicago - 8:00 AM - 12:00 PM
Presenting at 8:00am
Kathleen J Green, PhD
Research Presentation: TBA
Joseph L. Mayberry, Sr. Professor of Pathology
Professor of Dermatology
Associate Director of Basic Sciences, Robert H. Lurie
Comprehensive Cancer Center
Presenting at 10:45am
Michael D. Rosenblum, MD, PhD
Associate Professor of Dermatology
UCSF Department of Dermatology
At the conclusion of this activity, participants should be able to:
1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement:
Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.
Course Director Disclosure: Amy S. Paller, MD, MS has disclosed the following relevant financial relationships:
Serves as a consultant (with honoraria) for the following companies: AbbVie, Anacor Pharmaceuticals, Inc., Celgene Corporation, Chugai Pharma, Galderma Laboratories, L.P. LEO Pharma US, Novartis Pharmaceuticals Corp., Onset Dermatologics, Promius Pharma, LLC. Scioderm, Shire, and Stiefel a GSK company.
Serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Anacor Pharmaceuticals, Inc., Scioderm, and TopMD.
FSM s CME leadership and staff have nothing to disclose:
Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Manager of CME, Jen Banys, Senior Program Administrator, Allison McCollum, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.